BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4034877)

  • 21. Imaging dopamine receptors in the human brain by positron tomography.
    Wagner HN; Burns HD; Dannals RF; Wong DF; Langstrom B; Duelfer T; Frost JJ; Ravert HT; Links JM; Rosenbloom SB; Lukas SE; Kramer AV; Kuhar MJ
    Science; 1983 Sep; 221(4617):1264-6. PubMed ID: 6604315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prenatal reserpine exposure in rats decreases caudate nucleus dopamine receptor binding in female offspring.
    Ali SF; Buelke-Sam J; Slikker W
    Toxicol Lett; 1986 Jun; 31(3):195-201. PubMed ID: 3726897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Relation between brain D2-dopamine receptors and 3H-spiperone binding sites of intact lymphocytes].
    Noguchi-kuno SA; Nakata C; Nishitani H
    Rinsho Shinkeigaku; 1983 Sep; 23(9):814-8. PubMed ID: 6232031
    [No Abstract]   [Full Text] [Related]  

  • 24. 3H-Spiperone binding in normal and schizophrenic post-mortem human brain.
    Mackay AV; Doble A; Bird ED; Spokes EG; Quik M; Iversen LL
    Life Sci; 1978 Aug; 23(5):527-32. PubMed ID: 692277
    [No Abstract]   [Full Text] [Related]  

  • 25. Solubilization and characterization of 3H-spiroperidol binding sites of calf caudate.
    Lerner MH; Rosengarten H; Friedhoff AJ
    Life Sci; 1981 Dec; 29(23):2367-74. PubMed ID: 6172690
    [No Abstract]   [Full Text] [Related]  

  • 26. Are striatal [3H]spiperone radioreceptor assays indicative of multiple dopamine receptor interactions?
    Clements-Jewery S; Robson PA
    Neuropharmacology; 1981 Dec; 20(12B):1295-8. PubMed ID: 7322304
    [No Abstract]   [Full Text] [Related]  

  • 27. Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.
    Lee T; Seeman P; Tourtellotte WW; Farley IJ; Hornykeiwicz O
    Nature; 1978 Aug; 274(5674):897-900. PubMed ID: 683328
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification and partial purification of a hydrophobic protein component associated with [3H]spiroperidol-binding activity.
    Boyan-Salyers BD; Clement-Cormier Y
    Biochim Biophys Acta; 1980 Feb; 617(2):274-81. PubMed ID: 7357020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine receptor changes in schizophrenia in relation to the disease process and movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnstone EC; McCreadie RM; Owen F; Owens DG; Poulter M
    J Neural Transm Suppl; 1983; 18():265-72. PubMed ID: 6135745
    [No Abstract]   [Full Text] [Related]  

  • 30. Increased dopamine-receptor sensitivity in schizophrenia.
    Owen F; Cross AJ; Crow TJ; Longden A; Poulter M; Riley GJ
    Lancet; 1978 Jul; 2(8083):223-6. PubMed ID: 79025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased brain dopamine and dopamine receptors in schizophrenia.
    Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
    Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of phospholipase digestion and lysophosphatidylcholine on dopamine receptor binding.
    Oliveira CR; Duarte EP; Carvalho AP
    J Neurochem; 1984 Aug; 43(2):455-65. PubMed ID: 6736961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3H]Spiroperidol binding in bovine caudate nucleus [proceedings.
    Withy RM; Mayer RJ; Strange PG
    Biochem Soc Trans; 1980 Apr; 8(2):181-2. PubMed ID: 6245974
    [No Abstract]   [Full Text] [Related]  

  • 34. Altered expression and coregulation of dopamine signalling genes in schizophrenia and bipolar disorder.
    Zhan L; Kerr JR; Lafuente MJ; Maclean A; Chibalina MV; Liu B; Burke B; Bevan S; Nasir J
    Neuropathol Appl Neurobiol; 2011 Feb; 37(2):206-19. PubMed ID: 20874815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of multiple receptors for dopamine.
    Spano PF; Memo M; Stefanini E; Fresia P; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 21():243-51. PubMed ID: 7376971
    [No Abstract]   [Full Text] [Related]  

  • 36. The effect of typical and atypical neuroleptics on binding of [3H]spiroperidol in calf caudate.
    Lin CW; Maayani S; Wilk S
    J Pharmacol Exp Ther; 1980 Mar; 212(3):462-8. PubMed ID: 6102144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
    Hamblin MW; Creese I
    Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caerulein stimulates [3H]-spiperone binding in vivo after long-term haloperidol administration.
    Vasar E; Maimets M; Nurk A; Allikmets L
    Psychopharmacol Bull; 1984; 20(4):691-2. PubMed ID: 6494396
    [No Abstract]   [Full Text] [Related]  

  • 39. Estimation of the apparent affinity of the striatal dopamine receptors for the radioligand[3H]spiperone [( 3H]spiroperidol).
    Hruska RE
    J Neurosci Res; 1984; 12(4):571-81. PubMed ID: 6512888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of neuroreceptors in the living human brain: IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness.
    Wong DF; Pearlson GD; Tune LE; Young LT; Meltzer CC; Dannals RF; Ravert HT; Reith J; Kuhar MJ; Gjedde A
    J Cereb Blood Flow Metab; 1997 Mar; 17(3):331-42. PubMed ID: 9119906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.